Cepheid recently hosted an insightful webinar entitled ‘The importance of diagnosing respiratory symptoms and reliable performance of point-of-care testing.’
This interactive and educational session was presented by international expert speakers, and discussed issues currently being faced by healthcare providers worldwide.
Key topics included the recent emergence of circulating influenza A viruses with genetic drift, and how this increases the risk of false negatives during respiratory testing. The speakers also highlighted the potentially crucial role of fast and accurate RT-PCR-based point-of-care assays, such as the Cepheid Xpert® Xpress respiratory tests, for easing diagnostic bottlenecks and supporting disease control.
If you didn’t catch this fascinating webinar live, you can now watch the recording on-demand through this link.
